Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 18 Metastatic Castration-resistant Prostate Cancer 3 Prostatic Neoplasms, Castration-Resistant 2 Neoplasms 2 Metastatic Castration Resistant Prostate Cancer 2 Prostate Cancer Metastatic 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neoplasm Metastasis 1 Metastatic Castration-sensitive Prostate Cancer 1 Metastatic Castration-resistent Prostate Cancer 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Metastatic Castration-Resistant Prostate Cancer (mCRPC) 1 Breast Neoplasms 1 Abiraterone Acetate 1

Interventions

Prednisolone 1 BID protein, human 1 Androgen Antagonists 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Abiraterone Acetate × Abiraterone Acetate × Clear all

NCT06768255 2025-01-10

mCRPC

Fudan University

Phase 3 Not yet recruiting

Abiraterone Acetate

Data powered by HemOnc (CC BY 4.0) Colophon ⚡